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Abstract. Single-cell studies using noninvasive imaging is a challenging, yet appealing way to study cellular
characteristics over extended periods of time, for instance to follow cell interactions and the behavior of
different cell types within the same sample. In some cases, e.g., transplantation culturing, real-time cellular
monitoring, stem cell studies, in vivo studies, and embryo growth studies, it is also crucial to keep the sample
intact and invasive imaging using fluorophores or dyes is not an option. Computerized methods are needed to
improve throughput of image-based analysis and for use with noninvasive microscopy such methods are poorly
developed. By combining a set of well-documented image analysis and classification tools with noninvasive
microscopy, we demonstrate the ability for long-term image-based analysis of morphological changes in single
cells as induced by a toxin, and show how these changes can be used to indicate changes in biological function.
In this study, adherent cell cultures of DU-145 treated with low-concentration (LC) etoposide were imaged
during 3 days. Single cells were identified by image segmentation and subsequently classified on image fea-
tures, extracted for each cell. In parallel with image analysis, an MTS assay was performed to allow
comparison between metabolic activity and morphological changes after long-term low-level drug response.
Results show a decrease in proliferation rate for LC etoposide, accompanied by changes in cell morphology,
primarily leading to an increase in cell area and textural changes. It is shown that changes detected by image
analysis are already visible on day 1 for 0.25-μM etoposide, whereas effects on MTS and viability are detected
only on day 3 for 5-μM etoposide concentration, leading to the conclusion that the morphological changes
observed occur before and at lower concentrations than a reduction in cell metabolic activity or viability. Three
classifiers are compared and we report a best case sensitivity of 88% and specificity of 94% for classification
of cells as treated/untreated. © 2017 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10.1117/1.JMI.4.2.021106]
Keywords: single-cell studies; noninvasive microscopy; low-concentration etoposide; digital image cytometry; digital holographic
microscopy; cell classification.
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1 Introduction
When treating an organism with a substance in vivo, cells will
typically be exposed to a variety of concentrations, depending
on their location within the tissue and the body. Cells will
also react differently when exposed to the same concentration
depending on their cell type, tissue type, and sometimes stage
in the cell cycle. Most assays in use today study the average
characteristics of large groups of cells and are unable to show
the variability of the cell population. Single cells can be studied
using time-lapse imaging, with or without fluorescent markers
or dyes or using nonimaging marker-based techniques, such as
flow cytometry. The use of markers in cell imaging has several
disadvantages. It is indirect and invasive, and also makes the
cells unusable for further tests. In some cases, this is not pref-
erable, such as in studies of tissue or cells for transplantation, the
study of embryonic cells and stem cells, or when the sample
needs to be kept in a continuously viable condition for a longer
study. The study of single cells in vivo during long periods of
time requires the development of nondisturbing measurement
techniques in combination with appropriate methods of analysis,
many of which have yet to be developed. We evaluate one such
technique, where standard image analysis and classification
are combined with noninvasive microscopy and applied to a
toxicology study using etoposide, a cytotoxic drug with well-
described physiological effects. Etoposide is a chemotherapeutic
drug commonly used as an anticancer agent, causing DNA
damage and eventually triggering cell death by apoptosis at
high concentrations. The process at subapoptotic concentrations
and during long-term exposure is yet poorly understood, but
reports of effects include drug resistance and risk of secondary
leukemia (Sec. 1.1). To study the effects of long-term low-level
exposure, it is necessary to use an imaging set-up, where the
same cells can be monitored over time.
This study was motivated by the desire to be able to detect
the treatment concentration of etoposide by means of nonde-
structive image analysis of adherent cells in situ for long periods
of time on a cell-by-cell basis by means of morphological cues
(Fig. 1) induced by the toxin. We use a combination of digital
holographic microscopy (DHM) and image analysis to profile
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morphological changes in DU-145 cells,1,2 which we induce by
exposure to low-concentration (LC) etoposide, and model the
cells as a set of image-derived feature parameters. Cross corre-
lation with the known result is used to determine the most
prominent set of features. We then use the model to classify
the cells to the ground-truth treatment concentrations, and in
the end, we compare the result to that of a standard bulk
assay, the MTS, for reference. The classification is made on
a cell-by-cell basis with cells from cultures exposed to different
concentrations of etoposide. Cells are also combined using the
average over all cells in images from one sample in order to
make it possible to compare the results with the MTS assay,
where the evaluation is made on a culture-by-culture basis.
The MTS assay is a colorimetric method for sensitive quantifi-
cation of viable cells in proliferation and cytotoxicity assay.
It is based on reduction of the MTS solution, a tetrazolium com-
pound, by viable cells to generate a colored formazan product
that is soluble in cell culture media and detectable using a
spectrophotometer. The conversion is presumably accomplished
by NADPH or NADH produced by dehydrogenase enzymes in
metabolically active cells.3
1.1 Etoposide Toxic Effects
Etoposide has a long history as an anticancer agent4 and is
usually administered intravenously or orally in capsule form.
Etoposide has been reported to cause cell cycle arrest, which
has been tested previously using DHM.5,6 It functions by inter-
action with the enzyme topoisomerase II, causing breaks in the
DNA strand, ultimately leading to apoptosis,7,8 a process in
which cells also undergo morphological changes.9,10 Etoposide
is one of the most widely used chemotherapeutic agents for
several types of cancer,11–13 but its effect is limited by toxicity.11
It is shown14 that both the α and β types of topoisomerase II are
targeted by etoposide, but only at concentrations above or equal
to 1 μM, although some growth inhibition was observed at
lower concentrations. Bleibel et al.15 reported half maximal
inhibitory concentrations (IC_50) slightly below 1 μM, sug-
gesting that effects are also present at LC of etoposide. These
conclusions are confirmed by Liu et al.,16 who also found that
a lower limit for etoposide-induced proliferation and viability
reduction occurs at ∼0.02 μM and also shows effects on the
cell cycle at concentrations <1 μM (although for different cell
lines). Even lower concentrations were reported to cause
changes in phenotype and potentially also cause drug resistance
or cause secondary leukemia.17
1.2 Digital Holography
Dennis Gabor was the first to invent a way to encode the phase
of the light in a single recording, i.e., the hologram.18 The tech-
nique was later used as base for the development of digital
holography.19–22 Some years later, the first DHM images show-
ing living cells were published.23 Digital holography is a full-
field imaging technique, where pixel values are directly related
to cellular dry mass, and as the images from a mathematical
point of view are similar to those from a standard epifluores-
cence microscope, the same image analyzing algorithms can
often be used. In cellular biology, DHM has been used for a
number of applications, including in vivo studies,24 subcellular
motion within living tissue,25 migration studies,26–29 studies of
morphological changes,30–33 proliferation,34 and apoptosis.35
Figure 2 shows an example of typical morphological changes
in DU-145 cells treated with etoposide and compared with
the control.
2 Materials and Methods
2.1 Cell Culture
DU-145 cells (ATCC® HTB-81, ATCC LGC Standards,
Teddington, United Kingdom) were grown in 75 cm2 flasks
in Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen,
Carlsbad, California) cell culture media with an added 10%
fetal calf serum. Cells were subcultivated twice per week to
keep the culture nonconfluent.
2.2 Digital Holographic Microscopy Image Capture
For DHM tests, 2 × 104 cells per well were seeded in 6-well
plates (day 1). After 24-h incubation to allow the cells to attach,
fresh media with the desired concentration etoposide (Sigma-
Aldrich Co., St. Louis, Missouri dissolved in dimethyl sulfoxide
(DMSO) (Sigma-Aldrich) was added (day 0). Images of cells
were captured at days 1 to 3. The experiment was repeated for
Fig. 1 Algorithmic overview of the classification of cells exposed to a treatment, based on their imaged
morphological characteristics. Images are segmented and filtered, features extracted and used to train
a supervised classifier.
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etoposide concentrations c ¼ 0.25, 0.5, 1, and 5 μM. As DMSO
was used to dissolve etoposide, two controls were used:
untreated cells and cells in only DMSO. DHM images were cap-
tured using HoloMonitor M4 (Phase Holographic Imaging AB,
Lund, Sweden), using a 635-nm, 0.2 mW∕cm2 laser as the light
source. The 6-well plate was taken out of the incubator, the lid
was removed, and 15 images were captured from each well, after
which the lid was replaced and the plate was returned to the
incubator. All DHM images are 1024 × 1024 pixels, at a scale
of 0.51 μm∕pixel.
2.3 MTS Assay
Cells were seeded (day 1) into a 96-well plate at a density of
5 × 103 cells per well in 100 μl of cell culture medium. Six
wells per test condition were used. All unused wells were filled
with media including a blank column. After incubating for 24 h
to allow the cells to attach, the media was substituted for new
media with the desired test concentration (day 0). After 24, 48,
and 72 h, the plate was then analyzed using the MTS assay.
Etoposide was tested at c ¼ 0.25, 0.5, 1, and 5 μM, respectively.
As the etoposide was dissolved in DMSO, a column with only
DMSO equal to the amount in the wells with the most DMSO
(i.e., the wells with the highest concentration of etoposide) was
used as a secondary control. Twenty microliters of MTS
(Promega Corporation, Madison) was added to each well and
mixed by tapping the side of the plate. After incubating for
1 h and then again after 2 h, the plate was read using BIO-
TEK microplate reader at 490 nm.
2.4 Image Analysis
To identify single cells as regions of interest (ROI), images were
segmented with the microscope software HoloStudio™ (Phase
Holographic Imaging AB, Lund, Sweden), using a seeded
watershed segmentation.36 The half-elliptical shape of attached
adherent cells results in a thicker central part of each cell. Using
DHM, this is seen as a stronger signal, and it is straightforward
to extract cell centers using a combination of Gaussian smooth-
ing and H-maxima transform. The detected centers can then be
used as seeds. The original image, after applying a minimum
threshold (further described below) and inverting, is used as
image input for the watershed. The purpose of the threshold
is to reduce noise and somewhat flatten the image background
(the bottom of the cell culture vessel) and define cell borders.
After the watershed is complete and in a final noise reduction
step, segmented objects smaller than 20 pixels were discarded.
The most crucial step of the segmentation is the threshold setting
prior to segmentation. In this study, two implementations were
used. Otsu thresholding (OT)37 yielded a higher cut-off than
minimum error thresholding (MET),38 resulting in a more accu-
rate pinpointing of cells as out-of-focus debris in the growth
medium was not selected. On the other hand, MET gave a
more accurate cell outline (Fig. 3). In order to maintain the
accuracy of the border segmentation given in MET, while at the
same time restrict the selection to actual cells (and not sample
contamination or image artifacts), we introduced a new prepro-
cessing step, where we use both segmentation methods in
combination. The location of cells given by the segmentation
using OT was used to filter the noncellular bodies from the
segmentation using MET, thus gaining the advantages of both
methods.
We then proceeded to extract a set of gray-level image
features from each ROI to use as input for classification. The
purpose of this was to reduce the information in the image
(given as pixel by pixel) to only relevant variables for cell n,
EQ-TARGET;temp:intralink-;e001;326;171vðnÞ ¼ ðv1; v2; ; vm; : : : ; vM−1; vMÞ; (1)
where M is the number of variables gathered. We first collected
a set of 22 standard grayscale variables and cross correlated
them with the known result, using sample means. The features
for the treated cells that showed average differences from control
with a confidence of 95%, P < 0.05, were chosen for the model
and then used to classify single cells. A mathematical definition
of the selected variables is given in Sec. 2.6.
Fig. 2 Example of DU-145, (a) control and (b) 72 h after treatment with 0.5-μM etoposide, imaged with
digital holography. Image intensity is related to an optical phase shift, which is in turn related to cellular
dry mass.
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2.5 Proliferation
An estimate of the number of cells per culture vessel was calcu-
lated each day from the cell count given by the image analysis.
The number of cells was determined as the number of seg-
mented bodies in an image, using the MET after filtering by
OT, as described in Sec. 2.4. It has previously been shown
that a count using image analysis of DHM images is comparable
to operator cell count using a Bürker chamber34 and using the
image-based method instead of the manual, it is possible for
us to perform all measurements over 3 days in the same culture
vessel, not only saving time during the analysis but also remov-
ing one potential source of error.
2.6 Image Features
Define the original image Fðx; yÞ, with dimensions X and Y,
respectively, as a two-dimensional matrix of gray levels i, to
a maximum gray level I. Let ψ be the subset of F belonging
to the ROI of one cell selected in the segmentation (i.e., the
area), with perimeter ρ. Define each element of the gray-level
co-occurrence matrix (GLCM) Pði; jÞ of F as the number of
times gray level Fðx; yÞ ¼ i is oriented with respect to gray
level Fðxþ 1; yþ 1Þ ¼ j, where i; j ∈ ½0; G, and G < I is
the number of gray levels used in the GLCM. In our case,
G ¼ 8. The result is an intermediate matrix, whose values indi-
cate how often one pixel value in Fðx; yÞ tends to be similar to
its adjacent values. We normalize the GLCM so that
EQ-TARGET;temp:intralink-;e002;63;303
XG
i¼1
XG
j¼1
½Pði; jÞ ¼ 1: (2)
In this way, each value in Pði; jÞ will denote the probability of
a range of gray levels to appear in each others’ proximity. We
assume the cells to be randomly oriented, so we satisfy ourselves
with computing only one GLCM along the horizontal (x)
direction. For calculation of a roughness distribution Rðx; yÞ,
for each ψ we compute
EQ-TARGET;temp:intralink-;e003;63;186 ¼ Fðx; yÞ − Ω½Fðx; yÞ; (3)
whereΩ is a Gaussian smoothing filter, and ðx; yÞ ∈ ψ . Features
calculated from the GLCM are mean, standard deviation, energy
(angular second moment), entropy, contrast, and correlation.39
In addition, the following features are used for classification:
Cell area:
EQ-TARGET;temp:intralink-;e004;63;100 ¼
X
x
X
y
1; ðx; yÞ ∈ ψ ; (4)
Perimeter length:
EQ-TARGET;temp:intralink-;e005;326;593P ¼
X
x
X
y
1; ðx; yÞ ∈ ρ; (5)
Phase shift integral:
EQ-TARGET;temp:intralink-;e006;326;539Φtot ¼
X
x
X
y
Fðx; yÞ; (6)
Roughness kurtosis:
EQ-TARGET;temp:intralink-;e007;326;485 k ¼
1
A
P
x
P
y ½Rðx; yÞ − R¯4
σ4
; (7)
Roughness skewness:
EQ-TARGET;temp:intralink-;e008;326;430 s ¼
1
A
P
x
P
y ½Rðx; yÞ − R¯3
σ3
; (8)
Texture homogeneity:
EQ-TARGET;temp:intralink-;e009;326;374Shom ¼
XG
i¼1
XG
j¼1
Pði; jÞ
1 − jði − jÞj2 ; (9)
where σ is used to denote standard deviation and R¯ is the
average over the roughness R.
2.7 Classification
In order to classify single cells, we used three different methods
and attempted to classify cells into one of five classes, one for
each concentration of etoposide used. Methods used were a mul-
ticlass support vector machine (SVM), a Naïve Bayes classifier,
and a classification tree using random forests (RFs). For the
SVM, a linear kernel was used, and the hyperplane determined
by sequential minimal optimization.40 A multiclass SVM was
then constructed by combining binary SVMs pairwise in a direc-
tional acyclic graph.41 The Naïve Bayes classifier used a normal
Gaussian distribution estimating the prior probabilities from the
relative frequencies of the training classes.42 The RF used the
classification and regression tree algorithm,43 and the optimiza-
tion criterion was minimization of node impurity as defined by
Ginis diversity index. In order to reduce tree complexity and
avoid overfitting, we request that the tree (for 5-bin classifica-
tion) should have maximum 20 and minimum nine nodes. Nine
is the minimum number of nodes (including leaves) a binary
classification can contain with classification into five bins.
Very rarely, the tree from the training contained ≥30 nodes,
Fig. 3 Cell filtering using double thresholding. The same image (control day 1) segmented using
(a) MET, (b) OT, and (c) the result of MET, filtered using the OT to identify cells.
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severely overfitting the training data. A tree of 20 nodes will
classify into 13 bins and was chosen arbitrarily to be a large
enough number to cover any reasonable classification of 5
except obvious misses. Typical numbers of nodes were 10 to
15 per tree. For all methods, the training cells [rows of vðnÞ]
were selected randomly as 10% of the total number of available
N cells for that sample. The rest of the cells (the validation set)
were used to test the accuracy of the result by cross correlation.
The process of training and testing was repeated ten times, and
the results were averaged. The performance was evaluated using
a standard 4 core PC with 8-GB RAM, with the code imple-
mented in MATLAB R 7.12.0.635 (R2011a).
2.8 Statistics
Errors are given as 95% confidence intervals, unless otherwise
stated. To compute the P values, a two-tailed t-test was per-
formed. Experiments were repeated three times for concentra-
tion 0.25 μM, four times for 0.5 μM, twice for 1 μM, and
once for 5 μM. In 90 samples, a total of 66495 cells were
imaged, averaging 738 cells per sample.
3 Results
3.1 Observed Morphological Changes
Figure 4 shows typical changes in cell morphology for all five
concentrations of etoposide (including control) from day 1 to
day 3 after treatment. The control cells show normal exponential
cell growth, filling the culture vessel by day 3. Healthy cells
display a compact spindle or prolonged elliptic shape through-
out, with uniform cell size from day 1 to day 3. The 5-μM
concentration shows the most distinct case of toxicity, with
immediate arrest in cell growth and reduction in cell number
at days 2 and 3. Cell shapes are slightly round in day 1 and
mostly spherical in days 2 and 3 and are detached from the bot-
tom of the cell culture vessel. Concentrations from 0.25 to 1 μM
show intermediate stages of varying severity. Images from 1 μM
day 2; 0.25 μM day 3, and 0.5 μM days 2 and 3 show similar
morphological changes. These changes, which appear to be con-
sistent with onset of or low-level exposure to etoposide toxicity
have a rounded, flattened shape and increased cell area with
cells still attached to the bottom of the cell culture vessel. In
some cases, an increased granularity can be seen within cells,
though this may be caused by the increased area and flatness,
giving a higher contrast to variations in internal cellular structure
than can be seen in the healthy compact elliptical shape.
Qualitatively, it appears as if cell proliferation has been halted
at this stage, but with little or no increase in cell mortality, and
the cell number is approximately constant. In order to quantita-
tively study differences of etoposide-treated cells, we averaged
the features over all cells in each sample (Fig. 5) and compared
them to control. Most prominent were the differences for area,
perimeter length, and the integral of the phase shift. Physically,
these components are all related to the cell size, which is con-
sistent with the qualitatively observed changes.
3.2 MTS Correlation and Proliferation
From the daily segmentation of images, we obtain a count of cell
proliferation (Fig. 6). The cell growth for the control was close
to exponential, and a reduction in cell growth rate was detectable
for etoposide concentrations of 5 μM, consistent with the MTS
Fig. 4 Typical appearance of DU-145 imaged by digital holography after several days exposure to
LC-etoposide treatment.
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results (Fig. 7). It is notable that the morphological changes
were already detectable on day 1 with DHM for all examined
concentrations of etoposide, whereas changes in MTS absorb-
ance are only detectable for the highest concentration of
etoposide (5 μM) on day 3.
3.3 Cell Classification
With the five separate concentrations of etoposide, we had five
bins available for classification, but in a real-life situation, we do
not expect to know the concentration of the sample. In these
cases, it is of more interest to ask whether a sample is exposed
to some concentration c higher than some minimum value,
c ≥ cmin. In this case, the task is reduced to the binary problem
of classifying cells as being treated (c ≥ cmin) or not treated
(c < cmin). We use the sensitivity and specificity as indicators
of classification quality
EQ-TARGET;temp:intralink-;e010;326;242Sensitivity ¼ Eðc ≥ cminÞ ∪ Tðc ≥ cminÞ
Tðc ≥ cminÞ
; (10)
EQ-TARGET;temp:intralink-;e011;326;186Specificity ¼ Eðc < cminÞ ∪ Tðc < cminÞ
Tðc < cminÞ
; (11)
here, EðcÞ is the set of cells being classified as concentration c,
and TðcÞ is the set of cells actually exposed to concentration c.
There was a tendency for concentrations to be underestimated
and also a lower probability of separating control and 0.25 μM,
as well as of separating higher concentrations from each other.
We show a best case classification in separating control from
treated (etoposide <0.25 μM) at sensitivity and specificity of
Fig. 5 Variable values compared with control, calculated from
sample-wise mean. Day 1 (solid), day 2 (dashed), and day 3 (dotted)
after treatment. x -axis represents etoposide concentration; 0.25 μM
(diamond), 0.5 μM (square), and 1 μM (circle), respectively. Error
bars represent standard deviation, and for clarity, each series has
been slightly offset in x -direction. a) Area, b) Perimeter length,
c) Phaseshift sum, d) Roughness skewness, e) Roughness kurtosis,
f) Texture energy, g) Texture entropy, h) Texture contrast, i) Texture
correlation, j) Texture homogeneity.
Fig. 6 Proliferation curves for DU-145 under the effect of etoposide
0 μM (dashed), 0.25 μM (diamond), 0.5 μM (square), 1 μM (circle),
and 5 μM (cross). Measurements were taken at the same time, and
values for x -axis have been displaced slightly to display confidence
intervals.
Fig. 7 MTS absorbance as % of control days 2 and 3, as a function of
etoposide concentration, after 2 h of MTS incubation.
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88% 0.17 and 94% 0.001, respectively, for multiclass
SVM using OT. The skewness in accuracy describes a case
with more false negatives than false positives. The results
are similar for days 1 and 2, with incrementally reduced sen-
sitivity and simultaneously increased specificity at higher
concentrations. Figure 8 shows the receiver operating charac-
teristics (ROC) for classification based on the two original seg-
mentation methods, compared with the version with spatial
filtering of cells for all 3 days and methods of classification.
The data on 5 μM were very scarce due to very low number of
cells in each image (typically <10 cells), giving wide confi-
dence intervals in the results. The specificity was improved
throughout days 1 to 3 for all classifiers, reflecting the fact
that cell morphology becomes more and more distinct
(Fig. 4). In most cases, the multiclass SVM was the best clas-
sifier. It was closely matched by an RF, but the errors for the
RF were higher, especially when cell morphology differed
strongly. For day 1, there was only a marginal difference
between the three segmentation methods, but for days 2 and
3, the filtered thresholding gave the most reliable classification
for LC, and the OT is the most reliable classification for higher
concentrations (≥1 μM). We note a significant improvement in
specificity between 0.25 and 0.5 μM, most visible in day 3 for
Otsu and filtered thresholdings, but visible for all classifiers
and thresholds, reflecting the fact that cell morphology
changes more rapidly at these concentrations. The computa-
tional performance of the Naïve Bayes classifier was an
order of magnitude better than that of the SVM (Fig. 9),
whereas the RF ranked between these two methods.
Fig. 8 ROC for classification of cells exposed to etoposide (concentration increasing from right to left as
indicated in figure). Classifications used are SVM (top row), Naïve Bayes (middle row), and RF (bottom
row). Segmentation thresholds used are Otsu (solid square), minimum error (dashed triangle), and
filtered (dotted circle). Results have been grouped according to the day of measurement taken (a)–(c).
Fig. 9 Performance (computation time in seconds) for three classi-
fiers; SVM, Naïve Bayes, and RF as function of number of cells
classified.
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4 Discussion
We have demonstrated a method for image analysis, single-cell
segmentation, and cell classification for the analysis of drug
response of adherent in vitro cells over long periods of time.
We show that the changes induced are possible to detect at
an individual cell level and that analysis of morphological fea-
tures of cell systems under certain circumstances can be used to
test for changes in biological function. The morphological
changes observed do not directly correlate with the chemical
assay, but rather show complementary information. The key ele-
ments of the method are a nondestructive optical set-up and a
robust image analysis, segmentation, and classification. We
chose a seeded watershed segmentation because of its simplicity
and availability, but other segmentation methods may have
worked equally well. However, a common trait for all is the cor-
rect location of cell border, which had a large impact on clas-
sification performance. In our case, this was influenced by the
fact that one of the most prominent effects of LC-etoposide
exposure was the increase in cell area. For higher concentrations
of etoposide, the OT gave the most reliable classification,
whereas for lower concentrations (in the region, where only
the morphological changes were detected), the filtered thresh-
olding, with cell borders defined by the MET, gave a compa-
rable or better result. This can be due to the fact that cell
area is larger for treated cells and that the classification is
improved by a thresholding, which includes the cell perimeter.
Given the low overall probability to pinpoint the exposure
concentration of a single cell (for LC etoposide, a sensitivity
in the range of 70% to 90% with some exceptions), the SVM
seems to be the best choice of classifier, despite its longer com-
putational time. The classification of concentrations ≥0.25 μM
and control was the most reliable. For future experiments, we
would like to further examine the range of lower concentrations
(<0.25 μM). In our investigation, we focused on lower concen-
trations of etoposide, where cell growth is inhibited, but cell
number is not severely reduced, and this is reflected in the
low cell number available for analysis of the higher concentra-
tions etoposide (≥1 μM). The sensitivity of higher concentra-
tions etoposide could be readily increased by obtaining more
images per cell culture vessel, at the cost of longer capture time.
Except for the feature selection for the cell model, which was
done by directly cross correlating with the known result, the
parameters for both segmentation and classification were delib-
erately selected to be as little restrictive as possible by what is
known of the nature of the sample. This fact contributed to the
low sensitivity of the classification rate, and it may be possible
to achieve much higher accuracy by specifically tailoring the
analysis to expected phenotypical changes. The most obvious
way to achieve more detailed cell study would be an increase
in the microscope resolution. This would make it possible to
more accurately study cell interior, but would reduce the number
of cells available per image.
The most significant biological finding of this study is the
characterization of morphological changes at LC in the 0.25-
to 1-μM range of etoposide, where no effects are detectable by
MTS absorbance. The cell area is the most dominating morpho-
logical effect of long-term LC-etoposide exposure, but textural
changes are also prominent. The reasons for these changes have
yet to be examined, but may be connected to cell cycle arrest,
as they are accompanied by a reduction in proliferation rate.
Here, it is shown that changes are not directly related to
reduction in viability or metabolism, as detected by MTS.
For the three lowest concentrations, no reduction in viability
was detected for the 3 days examined. For all concentrations,
a reduction in proliferation rate accompanied that of morpho-
logical changes. For a future investigation, it would be of
interest to let the incubation proceed to investigate if viability
changes would occur in time. Also, by interrupting the exposure
to etoposide, it would be possible to examine if the effects of
etoposide are reversible or not.
The most important technical contribution is the demonstra-
tion of the usefulness of noninvasive image analysis when
examining long-term processes. For the purpose of obtaining
data over a long term, the system shows excellent promise.
We are able to study cells in the same sample over a 3-day
period, making it possible to study any changes occurring before
they are detectable by chemical assays. Performing all measure-
ments in the same culture vessel also removes the potential
source of error of using parallel samples. For the purpose of
classifying single cells depending on toxin exposure, the system
is less well suited, mainly due to the variety in individual
morphology of cells being larger than that induced by the toxin.
This stresses the fact that for individual cell studies, each cell
must be tracked throughout the sequence in order to detect
changes in appearance. One application for such a method is
the study of single cells continuously within the same culture.
This possibility opens up a whole new perspective on cellular
research, where cells are viewed not as a uniform mass, but
rather as a broad spectrum of individual bodies, all contributing
in its own way to the characteristics of the tissue.
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